By expenditures
| Name | Title | Type |
|---|---|---|
| Angela Rudolph | VP for Finance and Administration | Auditee |
| Adam Smith | Partner | Auditee |
| John Montgomery | CHIEF OF STAFF | Auditee |
| William Brickey | Partner | Auditee |
| Matthew Beattie | Controller | Auditee |
| Adam Smith | Partner | Auditee |
| No contacts on file | ||
| ID | Year | Date Accepted | Auditor | Spend |
|---|---|---|---|---|
| 349237 | 2024 | 2025-03-27 | Forvis Mazars LLP | $15.59M |
| 10595 | 2023 | 2024-01-10 | Forvis LLP | $16.42M |
| 50091 | 2022 | 2023-01-04 | Plante & Moran PLLC | $21.36M |
| Audit | Year | Accepted | Finding | Ref | Severity | Repeat | Requirement |
|---|---|---|---|---|---|---|---|
| 50091 | 2022 | 2023-01-04 | 621828 | 2022-005 | Significant Deficiency | - | L |
| 50091 | 2022 | 2023-01-04 | 621827 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621826 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621825 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 621824 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621823 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621822 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 621821 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621820 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621819 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 621818 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621817 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621816 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 621815 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621814 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621813 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 621812 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 621811 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 621810 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45386 | 2022-005 | Significant Deficiency | - | L |
| 50091 | 2022 | 2023-01-04 | 45385 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45384 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45383 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 45382 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45381 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45380 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 45379 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45378 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45377 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 45376 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45375 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45374 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 45373 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45372 | 2022-003 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45371 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 45370 | 2022-004 | Significant Deficiency | - | N |
| 50091 | 2022 | 2023-01-04 | 45369 | 2022-002 | Material Weakness | Yes | N |
| 50091 | 2022 | 2023-01-04 | 45368 | 2022-003 | Significant Deficiency | - | N |